Transcenta Grants 451,500 Award Shares and 22,500 Options, Equal to 0.11% of Share Capital, to 145 Employees Including One Director

Bulletin Express
Jun 30

On 30 June 2026, Transcenta-B (Transcenta) approved two equity incentives under its 2022 Share Incentive Scheme: a grant of 451,500 award shares to 136 employees and a separate grant of 22,500 share options to nine employees.

Key terms of the award-share grant • Size: 451,500 shares, representing about 0.10 % of issued share capital (excluding treasury shares). • Participants: 135 employees (421,500 shares) and Non-executive Director Dr Hansen Xu (30,000 shares). • Cost to grantees: Nil purchase price and nil consideration. • Vesting: One- to four-year schedule for employees; three-year schedule for Dr Xu. • Pricing reference: HK$1.18 per share, the closing price on the grant date. • Performance targets: None. • Clawback: Unvested shares may be forfeited upon death, disability, redundancy or termination for cause; retirement vests as scheduled unless otherwise decided by the scheme administrator.

Key terms of the option grant • Size: 22,500 options, convertible into the same number of shares, equal to roughly 0.005 % of issued share capital. • Exercise price: HK$1.18, set at the highest of the grant-date close (HK$1.18), the prior five-day average close (HK$1.15) and par value. • Vesting: Fully vest one year after grant; exercisable within ten years, but not earlier than 12 months from the grant date. • Performance targets: None. • Clawback: Unvested options forfeit upon death or permanent disability, subject to administrator discretion.

Regulatory compliance • The 30,000 award shares for Dr Hansen Xu were approved by the independent non-executive directors in line with Rule 17.04(1) of the Listing Rules; Dr Xu abstained from voting. • No individual participant exceeds the 1 % single-participant limit, and no related-entity participants or service providers are included. • No financial assistance was provided for share purchases.

Scheme capacity After these grants, 926,990 shares remain available under both the overall scheme mandate limit and the service-provider sub-limit.

Rationale Management states the incentives are designed to retain key talent, align employee interests with shareholders and reward contributions to the Group’s long-term growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10